NASDAQ: KRYS - Krystal Biotech, Inc.

Rentabilité sur six mois: +2.77%
Secteur: Healthcare

Calendrier des promotions Krystal Biotech, Inc.


À propos de l'entreprise

Krystal Biotech, Inc., биотехнологическая компания клинической стадии, занимается генной терапией повторного применения для лечения серьезных редких заболеваний в Соединенных Штатах. Его ведущим продуктом-кандидатом является беремаген геперпавек (B-VEC), который находится в фазе III клинических исследований по лечению дистрофического буллезного эпидермолиза.

Plus de détails
Компания также участвует в разработке препарата KB105, который находится в стадии I/II клинических исследований для лечения пациентов с дефицитным аутосомно-рецессивным врожденным ихтиозом; KB301, который находится на клинической стадии фазы I/II для лечения морщин и других проявлений стареющей или поврежденной кожи; KB407, который находится на доклинической стадии муковисцидоза; и KB104, который находится на доклинической стадии для синдрома Нетертона. Его кандидаты на продукты на стадии открытия включают KB5xx для лечения хронических кожных заболеваний, KB3xx для лечения эстетических состояний кожи и продукт KB3xx. Krystal Biotech, Inc. была основана в 2015 году и имеет штаб-квартиру в Питтсбурге, штат Пенсильвания.


EBITDA -0.0213
EV/EBITDA -35.82
Див.доход ао 0
Цена ао 168.44
Сайт https://www.krystalbio.com
ISIN US5011471027
P/BV 4.67
Число акций ао 0.02775 млрд
Выручка 0.0507
P/S 69.56
P/E 322.58
Валюта usd
IPO date 2017-09-20
Sector Health Care
Industry Biotechnology
Валюта отчета usd
Changement de prix par jour: -6.45% (180.13)
Changement de prix par semaine: -2.02% (171.98)
Changement de prix par mois: -13.26% (194.27)
Changement de prix sur 3 mois: -16.09% (200.83)
Changement de prix sur six mois: +2.77% (163.97)
Changement de prix par an: +49.22% (112.93)
Evolution du prix sur 3 ans: +226.57% (51.6)
Evolution du prix sur 5 ans: +281.68% (44.15)
Evolution des prix depuis le début de l'année: +65.17% (102.02)

Sous-estimation

Nom Signification Grade
P/S 67.78 1
P/BV 4.41 4
P/E 314.35 1
EV/EBITDA -33.47 0
Total: 3.13

Efficacité

Nom Signification Grade
ROA, % 1.34 1
ROE, % 1.4 1
Total: 1.5

Dividendes

Nom Signification Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Devoir

Nom Signification Grade
Debt/EBITDA -0.0878 10
Total: 8.4

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % 4969.9 10
Rentabilité Ebitda, % 402.84 10
Rentabilité EPS, % -132.82 0
Total: 6

Date de transaction Date de divulgation Insider Taper Prix Volume Quantité Partagez jusqu'à, % Partager après, % Document
11.06.2024 11.06.2024 Krishnan Krish S
President and CEO
Vente 175.76 4 394 000 25000 0 -0.1 lien
11.06.2024 11.06.2024 Krishnan Suma
President, R&D
Vente 175.77 4 394 250 25000 0 -0.1 lien
28.02.2024 01.03.2024 Krishnan Krish S
President and CEO
Achat 168.66 1 264 950 7500 0 0.03 lien
28.02.2024 01.03.2024 Krishnan Krish S
President and CEO
Achat 168.66 2 108 250 12500 0 0.05 lien
28.02.2024 01.03.2024 Krishnan Suma
President, R&D
Achat 168.66 2 108 250 12500 0 0.05 lien
28.02.2024 01.03.2024 Krishnan Suma
President, R&D
Achat 168.66 1 264 950 7500 0 0.03 lien
28.02.2024 01.03.2024 Romano Kathryn
Chief Accounting Officer
Vente 166.05 1 245 380 7500 0 -0.03 lien
28.02.2024 01.03.2024 Romano Kathryn
Chief Accounting Officer
Achat 63.55 476 625 7500 0 0.03 lien
28.02.2024 01.03.2024 Romano Kathryn
Chief Accounting Officer
Vente 165.88 829 400 5000 0 -0.02 lien
28.02.2024 01.03.2024 Romano Kathryn
Chief Accounting Officer
Achat 31.77 317 700 10000 0 0.04 lien
09.06.2023 09.06.2023 ORTH ANDREW C.
Chief Commercial Officer
Vente 128.61 1 607 620 12500 0 -0.05 lien
09.06.2023 09.06.2023 ORTH ANDREW C.
Chief Commercial Officer
Achat 63.55 794 375 12500 0 0.05 lien
09.06.2023 09.06.2023 JANNEY DANIEL
Director
Vente 128.77 2 438 260 18935 0 -0.08 lien
08.06.2023 09.06.2023 JANNEY DANIEL
Director
Vente 128.11 3 979 740 31065 0 -0.12 lien

Établissements Volume Partager, %
Avoro Capital Advisors LLC 2565555 9
Vanguard Group Inc 2435774 8.54
FMR, LLC 2385898 8.37
Blackrock Inc. 1809547 6.35
Redmile Group, LLC 1733189 6.08
State Street Corporation 1237497 4.34
Frazier Life Sciences Management, L.P. 988460 3.47
Jennison Associates LLC 724344 2.54
Lord, Abbett & Co. LLC 618458 2.17
Dimensional Fund Advisors LP 550806 1.93

ETF Partager, % Rentabilité pour l'année, % Dividendes, %
Jacob Forward ETF 2.70262 43.033162930921 0.15284
Franklin Genomic Advancements Fund Franklin Genomic Advancements Fund 4.53775 15.500403847566 0.22433
First Trust Active Factor Small Cap ETF 0.0841 34.251150665961 1.61948
Avantis U.S. Equity ETF 0.00221 30.365392144069 1.59151
Virtus LifeSci Biotech Products ETF 1.46245 36.788704846892 0.13953
JPMorgan BetaBuilders U.S. Small Cap Equity Fund 0.30479 24.74842126706 1.59225
ProShares Ultra Nasdaq Biotechnology 0.34659 51.697637072723 0.85651
BNY Mellon US Small Cap Core Equity ETF 0.23293 30.067895247333 1.75333
VictoryShares US Small Cap Volatility Wtd ETF 0.10182 30.077120822622 1.67818
VictoryShares US Discovery Enhanced Volatility Wtd ETF 0.10149 21.399562636676 1.67826
Dimensional U.S. Core Equity 2 ETF 0.01968 30.755198832543 1.47098
Dimensional US Core Equity Market ETF 0.01008 30.983243755928 1.40618
Dimensional U.S. Equity ETF 0.00632 31.530984204131 1.3557
Invesco Dorsey Wright SmallCap Momentum ETF 0.57748 33.912466843501 0.61241
Vanguard ESG U.S. Stock ETF 0.01 32.395678092399 1.26927
iShares ESG Aware MSCI USA Small-Cap ETF 0.04807 31.110458284371 1.49366
First Trust Multi Cap Growth AlphaDEX Fund 0.11915 41.560262822399 1.02425
Fidelity MSCI Health Care Index ETF 0.0587 16.20294599018 1.46057
First Trust US Equity Opportunities ETF 0.23204 -95.311633281972 0.69524
Fidelity Small-Mid Multifactor ETF 0.15442 32.307692307692 1.59943
First Trust Nasdaq BuyWrite Income ETF 0.13262 7.2708653353815 0.92977
First Trust Nasdaq Pharmaceuticals ETF 0.54366 18.366517675742 2.19901
First Trust Small Cap Growth AlphaDEX Fund 0.56792 42.49956240154 1.22182
First Trust Small Cap Core AlphaDEX Fund 0.28692 30.821917808219 1.87983
Goldman Sachs Innovate Equity ETF 0.08413 29.658020073179 1.20987
Goldman Sachs ActiveBeta US Small Cap Equity ETF 0.05689 31.359936575053 1.41955
ProShares Hedge Replication ETF 0.02777 5.9237999659878 1.47892
Humankind US Stock ETF 0.01926 18.809430395549 1.99919
Invesco Nasdaq Biotechnology ETF 0.50883 28.578975171685 0.8565
iShares Morningstar Small-Cap ETF 0.10009 30.095066471445 1.60498
iShares Morningstar Small-Cap Growth ETF 0.19941 33.628071953382 0.72598
iShares Russell 2000 Growth ETF 0.33761 38.042556988 0.6026
iShares Russell 3000 ETF 0.00827 31.230028873917 1.43482
John Hancock Multifactor Small Cap ETF 0.44188 29.343594166631 1.54912
iShares Morningstar Small-Cap ETF 0.10009 391.25300933451 1.60498
iShares Morningstar Small-Cap Growth ETF 0.19941 682.83677107207 0.72598
SPDR S&P Kensho New Economies Composite ETF 0.10429 28.602833414753 0.88486
Direxion Daily S&P Biotech Bull 3x Shares 0.64346 4067.9190751445 0.25924
First Trust Multi-Manager Small Cap Opportunities ETF 0.27344 48.514285714286 0.31756
SPDR S&P 1500 Momentum Tilt ETF 0.01375 38.251249368151 1.12176
Invesco Russell 2000 Dynamic Multifactor ETF 0.12351 23.041237113402 1.64004
Invesco FTSE RAFI US 1500 Small-Mid ETF 0.02867 32.025164769323 1.75869
Invesco S&P SmallCap Health Care ETF 3.24661 26.493323963457 0.41696
Invesco Dorsey Wright Healthcare Momentum ETF 1.8811 43.183192261185 0.12263
Invesco S&P SmallCap 600 Revenue ETF 0.00787 30.924461412599 1.94562
ProShares Ultra SmallCap600 0.24667 49.800399201597 1.83727
Schwab U.S. Small-Cap ETF 0.12925 -34.641922436355 1.51433
Schwab U.S. Broad Market ETF 0.00878 -56.193181818182 1.43354
SPDR S&P 600 Small Cap Growth ETF 0.46611 30.116139367241 1.33495
SPDR S&P 600 Small Cap Value ETF 0.23566 25.942561589765 2.34209
AlphaMark Actively Managed Small Cap ETF 0.92564 41.147942804763 1.74611
iShares MSCI USA Small-Cap Min Vol Factor ETF 0.1494 27.432590855803 1.66828
SPDR Portfolio MSCI Global Stock Market ETF 0.00004 23.658352229781 2.19607
SPDR Portfolio S&P 600 Small Cap ETF 0.34897 28.12583311117 1.84119
SPDR Portfolio S&P 1500 Composite Stock Market ETF 0.00881 30.865971972691 1.46083
Syntax Stratified SmallCap ETF 0.15893 13.508906292462 1.639
FlexShares Morningstar US Market Factor Tilt Index Fund 0.01563 31.776653355295 1.69572
Northern Lights Fund Trust IV 0.53119 36.85261707989 0.49246
Timothy Plan US Small Cap Core ETF 0.09547 30.162507436516 1.63049
ProShares UltraPro Russell2000 0.09866 89.821266282945 1.47873
Vanguard Small Cap Value ETF 0.07 29.200612557427 2.19419
Vanguard U.S. Momentum Factor ETF 0.11 45.845704753962 1.05834
Vanguard S&P Small-Cap 600 Growth ETF 0.5 30.308661092185 1.37064
Vanguard S&P Small-Cap 600 ETF 0.37 28.638920134983 1.89226
Vanguard S&P Small-Cap 600 Value ETF 0.25 26.289847650749 2.40883
Vanguard Russell 3000 ETF 0.01 31.87314172448 1.43817
Vanguard Russell 2000 Growth ETF 0.36 37.361289927043 0.60264
Vanguard Russell 2000 ETF 0.18 32.773459189339 1.48801
Vanguard Extended Market ETF 0.07 33.889077917659 1.34786
Principal Healthcare Innovators ETF 0.51487 618.4964157054 0.8416
Future Tech ETF 0.51487 426.33969118983 0.8416



Superviseur Titre d'emploi Paiement Année de naissance
Mr. Krish S. Krishnan M.B.A., M.S. Founder, Chairman, President & CEO 1.07M 1965 (59 années)
Ms. Suma M. Krishnan Founder, President of R&D and Director 789.92k 1965 (59 années)
Ms. Kathryn A. Romano Executive VP & Chief Accounting Officer 528.87k 1982 (42 année)
Mr. John Karakkal Vice President of North American Sales & Marketing N/A
Mr. Josh Suskin Director of Human Resources & Operations N/A
Mr. Laurent Goux Senior VP & GM of Europe N/A
Mr. John Thomas General Counsel & Corporate Secretary N/A
Ms. Christine Wilson Head of U.S. Sales & Marketing N/A
Dr. Stephane Paquette Ph.D. Vice President of Corporate Development
Mr. David Chien Senior Vice President of Clinical Development

Adresse: United States, Pittsburgh. PA, 2100 Wharton Street - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.krystalbio.com